Skip to main content
. 2022 Aug 2;25(8):104847. doi: 10.1016/j.isci.2022.104847

Table 4.

Respiratory manifestations of ANCA-positive patients in 2019 and 2021 with lung involvement

2019 (n = 3) 2021 (n = 21) p
ILD, n (%) 2 (66.6%) 12 (57.1%) 0.754
Haemoptysis/alveolar hemorrhage, n (%) 1 (33.3%) 5 (23.8%) 0.722
Nodules or cavities, n (%) 2 (9.5%)
Others, n (%) 2 (9.5%)

ILD, interstitial lung disease.